Guillain-Barré syndrome after exogenous gangliosides in Italy
Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome afte...
Gespeichert in:
| Veröffentlicht in: | BMJ 1993-12, Vol.307 (6917), p.1463-1464 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1464 |
|---|---|
| container_issue | 6917 |
| container_start_page | 1463 |
| container_title | BMJ |
| container_volume | 307 |
| creator | Landi, G D'Alessandro, R Dossi, B C Ricci, S Simone, I L Ciccone, A |
| description | Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome after taking them. |
| doi_str_mv | 10.1136/bmj.307.6917.1463 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1679501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>29721939</jstor_id><sourcerecordid>29721939</sourcerecordid><originalsourceid>FETCH-LOGICAL-b575t-474fd184a31d7b53afb4d606f58c9b807efe6a725e51226b2aa5143d7d0a8b053</originalsourceid><addsrcrecordid>eNqFkcuK1EAUhgtRxmacB3AhBHVp2rpfNgNj44wDrSKMl11xklTaatOpsSqR6UfyOXwxq0kTdCGuzuL7zs85_Ag9JnhJCJMvq912ybBaSkPUknDJ7qFFHroUmrH7aIGNMKUmTD9EZyltMcaUKW2kOEEnmmqCtV6g86vRdx34vnwFMf76WaR938SwcwW0g4uFuwsb14cxFRvoN50PyTcuFb4vrgfo9o_Qgxa65M6O8xR9vHx9s3pTrt9fXa8u1mUllBhKrnjbEM2BkUZVgkFb8UZi2Qpdm0pj5VonQVHhBKFUVhRAEM4a1WDQFRbsFJ1PubdjtXNN7fohQmdvo99B3NsA3v5Nev_VbsIPS6QyApMc8PQYEMP30aXBbsMY-3yzpZgZSRnmWXr2L4koJbnOYSpbZLLqGFKKrp3PINgemrG5GZubsYdm7KGZvPPkz_vnjWMPmT8_ckg1dG2EvvZp1pjmfPriGLNNQ4gzpkZRYpjJvJy4T4O7mznEb1YqpoR992ll3375rD6syaW9yf6LyT9c_P8vfgP8R70n</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776486797</pqid></control><display><type>article</type><title>Guillain-Barré syndrome after exogenous gangliosides in Italy</title><source>MEDLINE</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>JSTOR Archive Collection A-Z Listing</source><source>Alma/SFX Local Collection</source><creator>Landi, G ; D'Alessandro, R ; Dossi, B C ; Ricci, S ; Simone, I L ; Ciccone, A</creator><creatorcontrib>Landi, G ; D'Alessandro, R ; Dossi, B C ; Ricci, S ; Simone, I L ; Ciccone, A</creatorcontrib><description>Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome after taking them.</description><edition>International edition</edition><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 0959-8146</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.307.6917.1463</identifier><identifier>PMID: 8281088</identifier><identifier>CODEN: BMJOAE</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antibodies ; Biological and medical sciences ; Drug therapy ; Drug toxicity and drugs side effects treatment ; Female ; Gangliosides ; Gangliosides - adverse effects ; Humans ; Italy - epidemiology ; Low back pain ; Male ; Medical research ; Medical sciences ; Middle Aged ; Neurological disorders ; Neurology ; Pharmacology. Drug treatments ; Polyneuropathies ; Polyradiculoneuropathy - chemically induced ; Polyradiculoneuropathy - epidemiology ; Risk Factors ; Strokes ; Toxicity: nervous system and muscle</subject><ispartof>BMJ, 1993-12, Vol.307 (6917), p.1463-1464</ispartof><rights>Copyright 1993 British Medical Journal</rights><rights>1994 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Dec 4, 1993</rights><rights>Copyright BMJ Publishing Group Dec 4, 1993</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b575t-474fd184a31d7b53afb4d606f58c9b807efe6a725e51226b2aa5143d7d0a8b053</citedby><cites>FETCH-LOGICAL-b575t-474fd184a31d7b53afb4d606f58c9b807efe6a725e51226b2aa5143d7d0a8b053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/29721939$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/29721939$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,780,784,803,885,27924,27925,30999,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3844501$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8281088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Landi, G</creatorcontrib><creatorcontrib>D'Alessandro, R</creatorcontrib><creatorcontrib>Dossi, B C</creatorcontrib><creatorcontrib>Ricci, S</creatorcontrib><creatorcontrib>Simone, I L</creatorcontrib><creatorcontrib>Ciccone, A</creatorcontrib><title>Guillain-Barré syndrome after exogenous gangliosides in Italy</title><title>BMJ</title><addtitle>BMJ</addtitle><description>Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome after taking them.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies</subject><subject>Biological and medical sciences</subject><subject>Drug therapy</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Gangliosides</subject><subject>Gangliosides - adverse effects</subject><subject>Humans</subject><subject>Italy - epidemiology</subject><subject>Low back pain</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurological disorders</subject><subject>Neurology</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyneuropathies</subject><subject>Polyradiculoneuropathy - chemically induced</subject><subject>Polyradiculoneuropathy - epidemiology</subject><subject>Risk Factors</subject><subject>Strokes</subject><subject>Toxicity: nervous system and muscle</subject><issn>0959-8138</issn><issn>0959-8146</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkcuK1EAUhgtRxmacB3AhBHVp2rpfNgNj44wDrSKMl11xklTaatOpsSqR6UfyOXwxq0kTdCGuzuL7zs85_Ag9JnhJCJMvq912ybBaSkPUknDJ7qFFHroUmrH7aIGNMKUmTD9EZyltMcaUKW2kOEEnmmqCtV6g86vRdx34vnwFMf76WaR938SwcwW0g4uFuwsb14cxFRvoN50PyTcuFb4vrgfo9o_Qgxa65M6O8xR9vHx9s3pTrt9fXa8u1mUllBhKrnjbEM2BkUZVgkFb8UZi2Qpdm0pj5VonQVHhBKFUVhRAEM4a1WDQFRbsFJ1PubdjtXNN7fohQmdvo99B3NsA3v5Nev_VbsIPS6QyApMc8PQYEMP30aXBbsMY-3yzpZgZSRnmWXr2L4koJbnOYSpbZLLqGFKKrp3PINgemrG5GZubsYdm7KGZvPPkz_vnjWMPmT8_ckg1dG2EvvZp1pjmfPriGLNNQ4gzpkZRYpjJvJy4T4O7mznEb1YqpoR992ll3375rD6syaW9yf6LyT9c_P8vfgP8R70n</recordid><startdate>19931204</startdate><enddate>19931204</enddate><creator>Landi, G</creator><creator>D'Alessandro, R</creator><creator>Dossi, B C</creator><creator>Ricci, S</creator><creator>Simone, I L</creator><creator>Ciccone, A</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7QJ</scope><scope>5PM</scope></search><sort><creationdate>19931204</creationdate><title>Guillain-Barré syndrome after exogenous gangliosides in Italy</title><author>Landi, G ; D'Alessandro, R ; Dossi, B C ; Ricci, S ; Simone, I L ; Ciccone, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b575t-474fd184a31d7b53afb4d606f58c9b807efe6a725e51226b2aa5143d7d0a8b053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies</topic><topic>Biological and medical sciences</topic><topic>Drug therapy</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Gangliosides</topic><topic>Gangliosides - adverse effects</topic><topic>Humans</topic><topic>Italy - epidemiology</topic><topic>Low back pain</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurological disorders</topic><topic>Neurology</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyneuropathies</topic><topic>Polyradiculoneuropathy - chemically induced</topic><topic>Polyradiculoneuropathy - epidemiology</topic><topic>Risk Factors</topic><topic>Strokes</topic><topic>Toxicity: nervous system and muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Landi, G</creatorcontrib><creatorcontrib>D'Alessandro, R</creatorcontrib><creatorcontrib>Dossi, B C</creatorcontrib><creatorcontrib>Ricci, S</creatorcontrib><creatorcontrib>Simone, I L</creatorcontrib><creatorcontrib>Ciccone, A</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Landi, G</au><au>D'Alessandro, R</au><au>Dossi, B C</au><au>Ricci, S</au><au>Simone, I L</au><au>Ciccone, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Guillain-Barré syndrome after exogenous gangliosides in Italy</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>1993-12-04</date><risdate>1993</risdate><volume>307</volume><issue>6917</issue><spage>1463</spage><epage>1464</epage><pages>1463-1464</pages><issn>0959-8138</issn><issn>0959-8146</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><coden>BMJOAE</coden><abstract>Exogenous gangliosides are marketed in several countries and are used to treat many neurological diseases. A study reports 24 cases of the Guillain-Barre syndrome after ganglioside treatment in Italy. The drugs were withdrawn in Germany because six patients developed the Guillain-Barre syndrome after taking them.</abstract><cop>London</cop><pub>British Medical Journal Publishing Group</pub><pmid>8281088</pmid><doi>10.1136/bmj.307.6917.1463</doi><tpages>2</tpages><edition>International edition</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8138 |
| ispartof | BMJ, 1993-12, Vol.307 (6917), p.1463-1464 |
| issn | 0959-8138 0959-8146 1468-5833 1756-1833 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1679501 |
| source | MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); JSTOR Archive Collection A-Z Listing; Alma/SFX Local Collection |
| subjects | Adult Aged Aged, 80 and over Antibodies Biological and medical sciences Drug therapy Drug toxicity and drugs side effects treatment Female Gangliosides Gangliosides - adverse effects Humans Italy - epidemiology Low back pain Male Medical research Medical sciences Middle Aged Neurological disorders Neurology Pharmacology. Drug treatments Polyneuropathies Polyradiculoneuropathy - chemically induced Polyradiculoneuropathy - epidemiology Risk Factors Strokes Toxicity: nervous system and muscle |
| title | Guillain-Barré syndrome after exogenous gangliosides in Italy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A48%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Guillain-Barr%C3%A9%20syndrome%20after%20exogenous%20gangliosides%20in%20Italy&rft.jtitle=BMJ&rft.au=Landi,%20G&rft.date=1993-12-04&rft.volume=307&rft.issue=6917&rft.spage=1463&rft.epage=1464&rft.pages=1463-1464&rft.issn=0959-8138&rft.eissn=1468-5833&rft.coden=BMJOAE&rft_id=info:doi/10.1136/bmj.307.6917.1463&rft_dat=%3Cjstor_pubme%3E29721939%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776486797&rft_id=info:pmid/8281088&rft_jstor_id=29721939&rfr_iscdi=true |